EMBC · Embecta Corp.
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Cap structure and valuation
| Cap structure | |
|---|---|
| SP | $5.11 |
| SO | 56.7M |
| Options | 0.0M |
| Warrants | 0.0M |
| FD SO | 56.7M |
| MC | $289.5M |
| Cash | $214.7M |
| Total debt | $139.4M ⚠ |
| EV | $214.2M |
| TTM Multiples | |
|---|---|
| EV / Revenue | 0.2x |
| EV / EBITDA | — |
| MC / Net Income | 3.3x |
| EV / FCF | — |
| MC / FCF | — |
| Ownership & coverage | |
|---|---|
| Institutional | 88.1% |
| Insiders | 1.9% |
| # Institutions | 444 |
| Analysts | 2 |
| Consensus | Hold |
| Avg target | $4.00 |
| Short % float | 14.2% |
| Days to cover | 4.83 |
MC = SP × FD SO. EV = MC + Debt − Cash. SP = previous yfinance close. Balance-sheet figures as of 2026-07-31. Multiples use TTM (sum of last 4 quarters); shown as "—" when the denominator is zero or negative, or when fewer than four quarters are reported — a partial sum is not a trailing twelve months. Ownership & coverage per Yahoo Finance as of 2026-08-14 — institutional % is 13F-based, so it can lag a quarter and exceed 100% on share-count timing. Short interest per FINRA bi-monthly reporting, as of 2026-07-31; the float denominator can be unreliable on tiny floats.
Debt figure uncertain — overlapping debt tags exceeded total liabilities; clamped to a defensible bound (≈$1.35B dropped). Verify against the filing before relying on EV.
Financial statements
| 6/30/26 | 3/31/26 | 12/31/25 | 9/30/25 | |
|---|---|---|---|---|
| Total Revenue | 271.70 | 221.80 | 261.20 | 264.00 |
| Revenue YoY % | (8.1%) | (14.4%) | (0.3%) | (7.7%) |
| Cost of Revenue | 118.40 | 94.00 | 99.50 | 105.50 |
| Gross Profit | 153.30 | 127.80 | 161.70 | 158.50 |
| Gross Profit YoY % | (22.2%) | (22.1%) | 2.9% | (8.8%) |
| Gross Margin % | 56.4% | 57.6% | 61.9% | 60.0% |
| SG&A | 78.60 | 76.20 | 77.60 | 86.90 |
| R&D | 5.60 | 5.40 | 4.60 | 4.60 |
| Operating Expense | 104.60 | 92.80 | 78.40 | 102.00 |
| Operating Income | 48.70 | 35.00 | 83.30 | 56.50 |
| Operating Income YoY % | (48.2%) | (44.4%) | 190.2% | 115.6% |
| Operating Margin % | 17.9% | 15.8% | 31.9% | 21.4% |
| EBITDA | 59.30 | — | 93.60 | 69.60 |
| EBITDA Margin % | 21.8% | — | 35.8% | 26.4% |
| Other Income / (Expense) | (21.10) | (25.50) | (24.40) | (27.50) |
| Pretax Income | 27.60 | 9.50 | 58.90 | 29.00 |
| Tax Provision | 6.50 | 13.60 | 14.80 | 2.60 |
| Net Income | 21.10 | (4.10) | 44.10 | 26.40 |
| Net Margin % | 7.8% | (1.8%) | 16.9% | 10.0% |
| Diluted EPS | $0.36 | -$0.07 | $0.74 | $0.44 |
| Basic EPS | $0.36 | -$0.07 | $0.75 | $0.46 |
| Diluted Avg Shares | 58.5 | 59.3 | 59.3 | — |
| Basic Avg Shares | 58.5 | 59.3 | 58.8 | — |
| LTM | 9/30/25 | 9/30/24 | 9/30/23 | 9/30/22 | |
|---|---|---|---|---|---|
| Total Revenue | 1,018.70 | 1,080.40 | 1,123.10 | 1,120.80 | 1,129.50 |
| Revenue YoY % | (5.7%) | (3.8%) | 0.2% | (0.8%) | — |
| Cost of Revenue | 417.40 | 403.60 | 387.90 | 370.90 | 354.60 |
| Gross Profit | 601.30 | 676.80 | 735.20 | 749.90 | 774.90 |
| Gross Profit YoY % | (11.2%) | (7.9%) | (2.0%) | (3.2%) | — |
| Gross Margin % | 59.0% | 62.6% | 65.5% | 66.9% | 68.6% |
| SG&A | 319.30 | 332.00 | 365.10 | 341.30 | 294.80 |
| R&D | 20.20 | 37.30 | 78.80 | 85.20 | 66.90 |
| Operating Expense | 377.80 | 434.70 | 568.40 | 528.40 | 465.30 |
| Operating Income | 223.50 | 242.10 | 166.80 | 221.50 | 309.60 |
| Operating Income YoY % | (7.7%) | 45.1% | (24.7%) | (28.5%) | — |
| Operating Margin % | 21.9% | 22.4% | 14.9% | 19.8% | 27.4% |
| EBITDA | — | 282.80 | 203.00 | 254.10 | 341.30 |
| EBITDA Margin % | — | 26.2% | 18.1% | 22.7% | 30.2% |
| Other Income / (Expense) | (98.50) | (105.80) | (122.60) | (115.80) | (53.00) |
| Pretax Income | 125.00 | 136.30 | 44.20 | 105.70 | 256.60 |
| Tax Provision | 37.50 | 40.90 | (34.10) | 35.30 | 33.00 |
| Net Income | 87.50 | 95.40 | 78.30 | 70.40 | 223.60 |
| Net Margin % | 8.6% | 8.8% | 7.0% | 6.3% | 19.8% |
| Diluted EPS | $1.47 | $1.62 | $1.34 | $1.22 | $3.89 |
| Basic EPS | $1.50 | $1.64 | $1.36 | $1.23 | $3.92 |
| Diluted Avg Shares | 58.5 | 58.9 | 58.3 | 57.8 | 57.5 |
| Basic Avg Shares | 58.5 | 58.3 | 57.7 | 57.2 | 57.0 |
| 6/30/26 | 3/31/26 | 12/31/25 | 9/30/25 | |
|---|---|---|---|---|
| Cash & Equivalents | 214.70 | 184.90 | 201.30 | 225.50 |
| Receivables | 182.20 | 147.10 | 159.20 | 145.60 |
| Inventory | 214.20 | 192.60 | 181.80 | 178.60 |
| Other Current Assets | 94.00 | 83.50 | 77.90 | 81.70 |
| Total Current Assets | 705.10 | 608.10 | 620.20 | 631.40 |
| Net PPE | 316.80 | 237.50 | 248.90 | 257.20 |
| Operating Lease ROU | 18.20 | 17.50 | 19.10 | 20.20 |
| Goodwill | 39.90 | 15.40 | 15.40 | 15.40 |
| Intangible Assets | 47.50 | 6.50 | 6.70 | 7.00 |
| Other Assets | 137.80 | 144.30 | 153.40 | 159.70 |
| Total Assets | 1,265.30 | 1,029.30 | 1,063.70 | 1,090.90 |
| Current Debt | 139.40 | 9.50 | 9.50 | 9.50 |
| Current Lease Liabilities | 6.40 | 5.60 | 6.70 | 6.90 |
| Other Current Liabilities | 274.00 | 232.20 | 218.50 | 245.10 |
| Total Current Liabilities | 419.80 | 247.30 | 234.70 | 261.50 |
| Long-term Debt | 1,315.70 | 1,316.90 | 1,352.90 | 1,388.70 |
| Long-term Lease Liabilities | 9.30 | 9.20 | 9.50 | 10.20 |
| Other Liabilities | 133.20 | 82.00 | 79.70 | 81.10 |
| Total Liabilities | 1,878.00 | 1,655.40 | 1,676.80 | 1,741.50 |
| Retained Earnings | (404.30) | (424.70) | (411.10) | (445.60) |
| Total Equity | (612.70) | (626.10) | (613.10) | (650.60) |
| LTM | 9/30/25 | 9/30/24 | 9/30/23 | 9/30/22 | |
|---|---|---|---|---|---|
| Cash & Equivalents | 214.70 | 225.50 | 267.50 | 326.30 | 330.90 |
| Receivables | 182.20 | 145.60 | 193.00 | 16.70 | 22.20 |
| Inventory | 214.20 | 178.60 | 171.50 | 152.10 | 122.80 |
| Other Current Assets | 94.00 | 81.70 | 129.00 | 254.00 | 188.80 |
| Total Current Assets | 705.10 | 631.40 | 761.00 | 749.10 | 664.70 |
| Net PPE | 316.80 | 257.20 | 290.40 | 300.20 | 301.60 |
| Operating Lease ROU | 18.20 | 20.20 | 22.60 | 23.00 | 6.30 |
| Goodwill | 39.90 | 15.40 | 15.60 | 15.60 | 15.70 |
| Intangible Assets | 47.50 | 7.00 | 8.10 | 9.10 | 8.90 |
| Other Assets | 137.80 | 159.70 | 187.60 | 117.40 | 89.20 |
| Total Assets | 1,265.30 | 1,090.90 | 1,285.30 | 1,214.40 | 1,086.40 |
| Current Debt | 139.40 | 9.50 | 9.50 | 9.50 | 9.50 |
| Current Lease Liabilities | 6.40 | 6.90 | 6.00 | 5.90 | 2.00 |
| Other Current Liabilities | 274.00 | 245.10 | 358.50 | 338.10 | 289.50 |
| Total Current Liabilities | 419.80 | 261.50 | 374.00 | 353.50 | 301.00 |
| Long-term Debt | 1,315.70 | 1,388.70 | 1,565.30 | 1,593.90 | 1,598.10 |
| Long-term Lease Liabilities | 9.30 | 10.20 | 11.90 | 15.40 | 4.30 |
| Other Liabilities | 133.20 | 81.10 | 72.40 | 73.30 | 74.40 |
| Total Liabilities | 1,878.00 | 1,741.50 | 2,023.60 | 2,036.10 | 1,977.80 |
| Retained Earnings | (404.30) | (445.60) | (498.60) | (541.10) | (577.10) |
| Total Equity | (612.70) | (650.60) | (738.30) | (821.70) | (891.40) |
| 6/30/26 | 3/31/26 | 12/31/25 | 9/30/25 | |
|---|---|---|---|---|
| Net Income | 21.10 | (4.10) | 44.10 | 26.40 |
| D&A | 10.60 | — | 10.30 | 13.10 |
| Stock-Based Comp | 4.20 | 5.70 | 5.90 | 9.50 |
| Δ Working Cap & Other | 5.90 | — | (43.10) | 35.00 |
| Operating Cash Flow | 41.80 | — | 17.20 | 84.00 |
| CapEx | (1.10) | — | (0.60) | (7.30) |
| Other Investing | (128.40) | — | 10.10 | — |
| Investing Cash Flow | (129.50) | — | 9.50 | (7.30) |
| Debt Repayment | (2.40) | — | (37.50) | (72.40) |
| Dividends Paid | (0.60) | — | (8.90) | (8.80) |
| Other Financing | 115.40 | — | (5.20) | — |
| Financing Cash Flow | 112.40 | — | (51.60) | (81.60) |
| Free Cash Flow | 40.70 | — | 16.60 | 76.70 |
| LTM | 9/30/25 | 9/30/24 | 9/30/23 | 9/30/22 | |
|---|---|---|---|---|---|
| Net Income | 87.50 | 95.40 | 78.30 | 70.40 | 223.60 |
| D&A | — | 40.70 | 36.20 | 32.60 | 31.70 |
| Stock-Based Comp | 25.30 | 31.60 | 26.30 | 21.50 | 18.70 |
| Δ Working Cap & Other | — | 24.00 | (105.10) | (56.80) | 138.20 |
| Operating Cash Flow | — | 191.70 | 35.70 | 67.70 | 412.20 |
| CapEx | — | (9.30) | (15.80) | (26.50) | (23.60) |
| Investing Cash Flow | — | (9.30) | (15.80) | (26.50) | (24.00) |
| Debt Issuance | — | — | 0.00 | 0.00 | 1,450.00 |
| Debt Repayment | — | (184.60) | (34.60) | (9.50) | (4.80) |
| Dividends Paid | — | (35.00) | (34.50) | (34.40) | (8.60) |
| Other Financing | — | (7.10) | (4.30) | (4.80) | (1,484.60) |
| Financing Cash Flow | — | (226.70) | (73.40) | (48.70) | (48.00) |
| Free Cash Flow | — | 182.40 | 19.90 | 41.20 | 388.60 |
| 6/30/26 | 3/31/26 | 12/31/25 | 9/30/25 | |
|---|---|---|---|---|
| Current Ratio | 1.68 | 2.46 | 2.64 | 2.41 |
| Quick Ratio | 1.17 | 1.68 | 1.87 | 1.73 |
| Debt / Equity | -3.07 | -2.64 | -2.73 | -2.68 |
| EBITDA Margin % | 21.8% | — | 35.8% | 26.4% |
| Working Capital | 285.30 | 360.80 | 385.50 | 369.90 |
| Net Debt | 1,101.00 | 1,132.00 | 1,151.60 | 1,163.20 |
| ROE % | (3.4%) | 0.7% | (7.2%) | (4.1%) |
| ROA % | 1.7% | (0.4%) | 4.1% | 2.4% |
| LTM | 9/30/25 | 9/30/24 | 9/30/23 | 9/30/22 | |
|---|---|---|---|---|---|
| Current Ratio | 1.68 | 2.41 | 2.03 | 2.12 | 2.21 |
| Quick Ratio | 1.17 | 1.73 | 1.58 | 1.69 | 1.80 |
| Debt / Equity | -3.07 | -2.68 | -2.74 | -2.48 | -2.22 |
| EBITDA Margin % | — | 26.2% | 18.1% | 22.7% | 30.2% |
| Working Capital | 285.30 | 369.90 | 387.00 | 395.60 | 363.70 |
| Net Debt | 1,101.00 | 1,163.20 | 1,297.80 | 1,267.60 | 1,267.20 |
| ROE % | (14.3%) | (14.7%) | (10.6%) | (8.6%) | (25.1%) |
| ROA % | 6.9% | 8.7% | 6.1% | 5.8% | 20.6% |
Insider activity (last 2 years)
| Date Filed | Reporter | Relationship | Trans. Date | Code | Shares | Price | Total Value |
|---|---|---|---|---|---|---|---|
| 2026-08-13 | Kurdikar Devdatt | Director, Officer (President and CEO) | 2026-08-12 | P | 30,000 | $4.70 | $140,937 |
| 2026-08-13 | Elguicze Jacob | Officer (SVP and CFO) | 2026-08-12 | P | 20,000 | $4.67 | $93,360 |
| 2026-08-13 | Mann Jeffrey Z | Officer (Pres, Pharm Svc&Prod Mgmt, CLO) | 2026-08-12 | P | 20,000 | $4.99 | $99,800 |
| 2026-08-13 | HOMBACH ROBERT J. | Director | 2026-08-12 | P | 45,000 | $4.97 | $223,848 |
| 2026-08-11 | Casner Jean | Officer (Chief Human Resources Officer) | 2026-08-09 | F | (1,480) | $4.42 | -$6,542 |
| 2026-06-02 | Roth Anthony M. | Officer (VP, Chief Accounting Officer) | 2026-06-01 | A | 30,000 | — | $0 |
| 2026-02-13 | Anderson Carrie L | Director | 2026-02-11 | A | 22,841 | — | $0 |
| 2026-02-13 | HOMBACH ROBERT J. | Director | 2026-02-11 | A | 22,841 | — | $0 |
| 2026-02-13 | Morris Milton Mayo | Director | 2026-02-11 | A | 22,841 | — | $0 |
| 2026-02-13 | Prange Karen | Director | 2026-02-11 | A | 22,841 | — | $0 |
| 2026-02-13 | Pomeroy Claire | Director | 2026-02-11 | A | 22,841 | — | $0 |
| 2026-02-13 | Reidy Christopher R | Director | 2026-02-11 | A | 22,841 | — | $0 |
| 2025-12-01 | Roth Anthony M. | Officer (Chief Accounting Officer) | 2025-11-26 | A | 32,817 | — | $0 |
| 2025-12-01 | Roth Anthony M. | Officer (Chief Accounting Officer) | 2025-11-26 | F | (1,881) | $12.57 | -$23,644 |
| 2025-12-01 | Casner Jean | Officer (Chief Human Resources Officer) | 2025-11-26 | A | 38,783 | — | $0 |
| 2025-12-01 | Casner Jean | Officer (Chief Human Resources Officer) | 2025-11-26 | F | (3,325) | $12.57 | -$41,795 |
| 2025-12-01 | Mann Jeffrey Z | Officer (SVP, GC, Head Corp. Dev., Secy) | 2025-11-26 | A | 79,555 | — | $0 |
| 2025-12-01 | Mann Jeffrey Z | Officer (SVP, GC, Head Corp. Dev., Secy) | 2025-11-26 | A | 24,495 | — | $0 |
| 2025-12-01 | Mann Jeffrey Z | Officer (SVP, GC, Head Corp. Dev., Secy) | 2025-11-26 | F | (19,605) | $12.57 | -$246,435 |
| 2025-12-01 | Kurdikar Devdatt | Director, Officer (President and CEO) | 2025-11-26 | A | 288,386 | — | $0 |
| 2025-12-01 | Kurdikar Devdatt | Director, Officer (President and CEO) | 2025-11-26 | A | 103,626 | — | $0 |
| 2025-12-01 | Kurdikar Devdatt | Director, Officer (President and CEO) | 2025-11-26 | F | (128,630) | $12.57 | -$1,616,879 |
| 2025-12-01 | Elguicze Jacob | Officer (SVP and CFO) | 2025-11-26 | A | 95,466 | — | $0 |
| 2025-12-01 | Elguicze Jacob | Officer (SVP and CFO) | 2025-11-26 | A | 30,147 | — | $0 |
| 2025-12-01 | Elguicze Jacob | Officer (SVP and CFO) | 2025-11-26 | F | (24,782) | $12.57 | -$311,510 |
| 2025-12-01 | Curtis Shaun | Officer (SVP, Global Manuf./Sup. Chain) | 2025-11-26 | A | 37,789 | — | $0 |
| 2025-12-01 | Curtis Shaun | Officer (SVP, Global Manuf./Sup. Chain) | 2025-11-26 | A | 11,305 | — | $0 |
| 2025-12-01 | Curtis Shaun | Officer (SVP, Global Manuf./Sup. Chain) | 2025-11-26 | F | (15,380) | $12.57 | -$193,327 |
| 2025-08-11 | Casner Jean | Officer (Chief Human Resources Officer) | 2025-08-09 | F | (916) | $12.28 | -$11,248 |
| 2025-05-23 | Melcher David F | Director | 2025-05-23 | P | 10,000 | $10.60 | $105,995 |
| 2025-04-08 | Elguicze Jacob | Officer (SVP and CFO) | 2025-04-04 | F | (4,948) | $12.00 | -$59,376 |
| 2025-04-08 | Curtis Shaun | Officer (SVP, Global Manuf./Sup. Chain) | 2025-04-04 | F | (3,249) | $12.00 | -$38,988 |
| 2025-04-08 | Mann Jeffrey Z | Officer (SVP, GC, Head Corp. Dev., Secy) | 2025-04-04 | F | (5,285) | $12.00 | -$63,420 |
| 2025-04-08 | Kurdikar Devdatt | Director, Officer (President and CEO) | 2025-04-04 | F | (39,592) | $12.00 | -$475,104 |
| 2025-02-25 | Melcher David F | Director | 2025-02-25 | P | 13,000 | $13.67 | $177,646 |
| 2025-02-14 | Morris Milton Mayo | Director | 2025-02-13 | S | (3,100) | $16.38 | -$50,783 |
| 2025-02-14 | Morris Milton Mayo | Director | 2025-02-12 | A | 13,839 | — | $0 |
| 2025-02-14 | Albritton David | Director | 2025-02-12 | A | 13,839 | — | $0 |
| 2025-02-14 | Anderson Carrie L | Director | 2025-02-12 | A | 13,839 | — | $0 |
| 2025-02-14 | Prange Karen | Director | 2025-02-12 | A | 13,839 | — | $0 |
| 2025-02-14 | Reidy Christopher R | Director | 2025-02-12 | A | 13,839 | — | $0 |
| 2025-02-14 | Pomeroy Claire | Director | 2025-02-12 | A | 13,839 | — | $0 |
| 2025-02-14 | HOMBACH ROBERT J. | Director | 2025-02-12 | A | 13,839 | — | $0 |
| 2025-02-14 | Melcher David F | Director | 2025-02-12 | A | 17,450 | — | $0 |
| 2024-12-04 | Roth Anthony M. | Officer (Chief Accounting Officer) | 2024-12-02 | A | 15,762 | — | $0 |
| 2024-11-29 | Elguicze Jacob | Officer (SVP and CFO) | 2024-11-26 | A | 61,498 | — | $0 |
| 2024-11-29 | Elguicze Jacob | Officer (SVP and CFO) | 2024-11-26 | F | (9,785) | $18.70 | -$182,980 |
| 2024-11-29 | Curtis Shaun | Officer (SVP, Global Manuf./Sup. Chain) | 2024-11-26 | A | 24,065 | — | $0 |
| 2024-11-29 | Curtis Shaun | Officer (SVP, Global Manuf./Sup. Chain) | 2024-11-26 | F | (5,806) | $18.70 | -$108,572 |
| 2024-11-29 | Kurdikar Devdatt | Director, Officer (President and CEO) | 2024-11-26 | A | 187,166 | — | $0 |
| 2024-11-29 | Kurdikar Devdatt | Director, Officer (President and CEO) | 2024-11-26 | F | (48,956) | $18.70 | -$915,477 |
| 2024-11-29 | Mann Jeffrey Z | Officer (SVP, GC, Head Corp. Dev., Secy) | 2024-11-26 | A | 50,803 | — | $0 |
| 2024-11-29 | Mann Jeffrey Z | Officer (SVP, GC, Head Corp. Dev., Secy) | 2024-11-26 | F | (8,016) | $18.70 | -$149,899 |
| 2024-11-29 | Casner Jean | Officer (Chief Human Resources Officer) | 2024-11-26 | A | 23,396 | — | $0 |
| 2024-11-29 | Casner Jean | Officer (Chief Human Resources Officer) | 2024-11-26 | F | (1,281) | $18.70 | -$23,955 |